期刊文献+

MDM2-p53信号通路在结直肠癌发生和发展中的作用 被引量:4

Role of MDM2-p53 signaling pathway in the development of colorectal cancer
原文传递
导出
摘要 目的探究MDM2-p53信号通路在结直肠癌发生和发展中的作用机制,以及p53表达与临床病理参数间的关系,进一步分析其对长期预后的影响。方法收集86例患者的结直肠癌组织及癌旁正常组织。分别通过免疫组化、蛋白印迹、实时荧光定量法测定结直肠癌及癌旁正常组织中p53和鼠双微基因2(MDM2)的表达。采用Kaplan-Meier生存曲线对患者进行预后分析。结果在结直肠癌组织中p53和MDM2的蛋白表达与mRNA表达水平均明显高于癌旁组织(均P<0.01),且二者表达呈现正相关(r=0.785)。结直肠癌组织中p53的表达与肿瘤分化程度、TNM分期、淋巴结转移、浸润深度临床病理特征有关(均P<0.05)。p53高表达组平均总生存时间为(53.92±1.56)个月,明显低于p53低表达组的平均总生存时间(69.16±3.72)个月,差异有统计学意义(χ2=14.78,P<0.01)。结论结直肠癌的发病风险及预后与MDM2-p53信号通路密切相关,p53可作为结直肠癌预后和治疗效果的潜在靶点。 Objective To investigate the mechanism of MDM2-p53 signaling pathway in the development of colorectal cancer and correlation between p53 with clinicopathological parameters, so as to further analyze the effect of p53 on prognosis. Methods The colorectal cancer tissues and the adjacent normal tissues from 86 cases of patients with colorectal cancer were collected. The expression of p53 and murine double minute 2(MDM2) in colorectal cancer and adjacent normal tissues were detected by immunohistochemistry, Western Blot and real-time fluorescence quantitative polymerase chain reaction (RT-PCR). The prognosis of the patients was analyzed by the Kaplan-Meier survival curves. Results The protein expression and the mRNA expression of p53 and MDM2 in colorectal cancer tissues were significantly higher than that in the adjacent non-cancerous tissues (all P<0.01). A positive correlation was observed between the expression of p53 and MDM2 (r=0.785). The expression of p53 in colorectal cancer tissues were correlated well with the degree of tumor differentiation, TNM stage, lymph node metastasis and infiltration depth (all P<0.05). Survival analysis demonstrated that the mean overall survival time in p53 high expression group was (53.92±1.56) months which was significantly lower than that in p53 low expression group of (69.16±3.72) months, and the difference was statistically significant (χ2=14.78, P<0.01). Conclusions The risk and prognosis of colorectal cancer are closely related to the MDM2-p53 signaling pathway. p53 can be used as a potential target for the prognosis and treatment of colorectal cancer.
作者 郝敬鹏 东帅 何彬 韩梅 李梦龙 李鹏昊 郑冰 王晖 Hao Jingpeng;Dong Shuai;He Bin;Han Mei;Li Menglong;Li Penghao;Zheng Bing;Wang Hui(Department of Anorectal Surgery, the Second Hospital of Tianjin Medical University, Tianjin 300211, China)
出处 《国际生物医学工程杂志》 CAS 2019年第1期27-32,共6页 International Journal of Biomedical Engineering
关键词 结直肠癌 P53 鼠双微基因2 临床病理特征 信号通路 预后 Colorectal cancer p53 Murine double minute 2 Clinicopathological features Signaling pathway Prognosis
  • 相关文献

参考文献7

二级参考文献41

  • 1Dong-Mei Li,Jun Zhang,Wen-Mei Li,Jian-Tao Cui,Yuan-Ming Pan,Si-Qi Liu,Rui Xing,You-Yong Lu.MAWBP and MAWD inhibit proliferation and invasion in gastric cancer[J].World Journal of Gastroenterology,2013,19(18):2781-2792. 被引量:5
  • 2张常华,何裕隆,詹文华,王方金,汪建平,蔡世荣,黄美近.多发性结直肠癌中抑癌基因p53的表达与突变[J].中华实验外科杂志,2005,22(3):305-306. 被引量:11
  • 3Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene 0^6methylguanine-DNA methytransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis [J]. Cancer Res,2000,60(9) :2368-2371.
  • 4Oue N, Oshimo Y, ho R, et al. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype [J ]. Cancer Sci, 2003,94(10) : 901-905.
  • 5Buccoliero A M, Arganini L, Ammannati F, et al. Oligodendrogliomas lacking 0^6-methylguanine-DNA-methyhransferase expression [ J ]. J Chemother, 2005,17 (3) : 321-326.
  • 6Kawaguchi K, Oda Y, Saito T, et al. DNA hypermethylation status of multiple genes in soft tissue sarcomas [J]. Mod Pathol,2006,19 (1) : 106-114.
  • 7Abdel-Fattah R, Gliek A, Rehman I, et al. Methylation of the 0^6- methylguanine-DNA methyhransferase promoter suppresses expression in mouse skin tumors and varises with the tumor induction protocol [J]. Int J Cancer,2006, 118(3) :527-531.
  • 8Furonaka O, Takeshima Y, Awaya H, et al. Aberrant methylation and loss of expression of 0-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma [J]. Pathol lnt, 2005,55 (6) : 303-309.
  • 9Koga Y, Kitajima Y, Miyoshi A, et al. Tumor progression through epigenetic geng silencing of 0 (6)-methylguanine-DNA methyltransferase in human biliary tract cancers[J]. Ann Surg Oncol, 2005,12 (5) : 342-343.
  • 10Matsukura S, Miyazaki K, Yakushiji H, et al. Expression and prognostic significance of 0^6 methylguanine-DNA methyltransferase in hepatocellular, gastric, and breast cancers [ J ]. Ann Surg Oncol, 2001,8 (10) : 807-816.

共引文献85

同被引文献35

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部